PortfoliosLab logoPortfoliosLab logo
DY vs. ANAB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

DY vs. ANAB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dycom Industries, Inc. (DY) and AnaptysBio, Inc. (ANAB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DY achieves a 38.80% return, which is significantly lower than ANAB's 73.48% return.


DY

1D
0.95%
1M
5.44%
YTD
38.80%
6M
35.64%
1Y
99.12%
3Y*
64.20%
5Y*
42.09%
10Y*
18.68%

ANAB

1D
3.37%
1M
-10.55%
YTD
73.48%
6M
87.15%
1Y
259.27%
3Y*
64.14%
5Y*
28.21%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

DY vs. ANAB - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
DY
Dycom Industries, Inc.
38.80%94.13%51.24%22.96%-0.17%24.15%60.17%-12.75%-51.50%36.82%
ANAB
AnaptysBio, Inc.
73.48%266.16%-38.19%-30.88%-10.82%61.63%32.31%-74.53%-36.67%529.50%

Correlation

The correlation between DY and ANAB is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.22

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Jan 26, 2017

0.21

Fundamentals

Market Cap

DY:

$14.25B

ANAB:

$1.61B

EPS

DY:

$10.52

ANAB:

-$0.91

PS Ratio

DY:

2.22

ANAB:

7.11

PB Ratio

DY:

7.52

ANAB:

126.20

Total Revenue (TTM)

DY:

$6.25B

ANAB:

$232.39M

Gross Profit (TTM)

DY:

$1.23B

ANAB:

$245.59M

EBITDA (TTM)

DY:

$1.07B

ANAB:

$52.72M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DY vs. ANAB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DY
DY Risk / Return Rank: 9191
Overall Rank
DY Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
DY Sortino Ratio Rank: 9191
Sortino Ratio Rank
DY Omega Ratio Rank: 8989
Omega Ratio Rank
DY Calmar Ratio Rank: 9090
Calmar Ratio Rank
DY Martin Ratio Rank: 9292
Martin Ratio Rank

ANAB
ANAB Risk / Return Rank: 9696
Overall Rank
ANAB Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
ANAB Sortino Ratio Rank: 9595
Sortino Ratio Rank
ANAB Omega Ratio Rank: 9595
Omega Ratio Rank
ANAB Calmar Ratio Rank: 9797
Calmar Ratio Rank
ANAB Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DY vs. ANAB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dycom Industries, Inc. (DY) and AnaptysBio, Inc. (ANAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


DYANABDifference
Sharpe ratioReturn per unit of total volatility

-1.61

Sortino ratioReturn per unit of downside risk

-0.79

Omega ratioGain probability vs. loss probability

1.39

1.53

-0.14

Calmar ratioReturn relative to maximum drawdown

4.08

9.28

-5.20

Martin ratioReturn relative to average drawdown

13.38

22.38

-8.99

DY vs. ANAB - Sharpe Ratio Comparison

The current DY Sharpe Ratio is 2.19, which is lower than the ANAB Sharpe Ratio of 3.80. The chart below compares the historical Sharpe Ratios of DY and ANAB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

DY vs. ANAB - Drawdown Comparison

The maximum DY drawdown since its inception was -93.54%, roughly equal to the maximum ANAB drawdown of -92.08%. Use the drawdown chart below to compare losses from any high point for DY and ANAB.


Loading charts...

Drawdown Indicators


DYANABDifference

Max Drawdown

Largest peak-to-trough decline

-93.54%

-92.08%

-1.46%

Max Drawdown (1Y)

Largest decline over 1 year

-24.43%

-28.15%

+3.72%

Max Drawdown (3Y)

Largest decline over 3 years

-32.58%

-69.32%

+36.74%

Max Drawdown (5Y)

Largest decline over 5 years

-33.70%

-69.32%

+35.62%

Max Drawdown (10Y)

Largest decline over 10 years

-89.01%

Current Drawdown

Current decline from peak

-12.37%

-34.57%

+22.20%

Average Drawdown

Average peak-to-trough decline

-45.66%

-64.64%

+18.98%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.43%

11.64%

-4.21%

Volatility

DY vs. ANAB - Volatility Comparison

Dycom Industries, Inc. (DY) has a higher volatility of 26.09% compared to AnaptysBio, Inc. (ANAB) at 12.40%. This indicates that DY's price experiences larger fluctuations and is considered to be riskier than ANAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


DYANABDifference

Volatility (1M)

Calculated over the trailing 1-month period

26.09%

12.40%

+13.69%

Volatility (6M)

Calculated over the trailing 6-month period

38.40%

46.31%

-7.91%

Volatility (1Y)

Calculated over the trailing 1-year period

45.60%

68.78%

-23.18%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

43.51%

65.31%

-21.80%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

52.93%

75.44%

-22.51%

Dividends

DY vs. ANAB - Dividend Comparison

Neither DY nor ANAB has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

DY vs. ANAB - Financials Comparison

This section allows you to compare key financial metrics between Dycom Industries, Inc. and AnaptysBio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B20222023202420252026
1.96B
25.56M
(DY) Total Revenue
(ANAB) Total Revenue
Values in USD except per share items

Frequently Asked Questions


DY and ANAB have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

DY has higher volatility (26.09%) compared to ANAB (12.40%). In terms of maximum drawdown, DY dropped -93.54% vs ANAB's -92.08%.

ANAB currently has the higher Sharpe Ratio (3.80 vs 2.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for DY and ANAB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer